AC Immune SA (IMR.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR

Add to watchlist

2.2800

+0.0150

(+0.66%)

At close: 03:32PM CEST

Loading interactive chart…

Simply Wall St.
We Think AC Immune (NASDAQ:ACIU) Can Afford To Drive Business Growth
We can readily understand why investors are attracted to unprofitable companies. For example, although...
Simply Wall St.
Further weakness as AC Immune (NASDAQ:ACIU) drops 12% this week, taking three-year losses to 58%
AC Immune SA ( NASDAQ:ACIU ) shareholders should be happy to see the share price up 17% in the last month. But over the...
GlobeNewswire
AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update
AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update ACI-24.060 ABATE Phase 2 trial to report Abeta-PET imaging results in Q2 and H2ACI-7104.056 VacSYn Phase 2 trial in Parkinson’s disease on track for interim data in H2ACI-24.060 for Alzheimer’s disease (AD) received FDA Fast Track designationACI-35.030 ReTain Phase 2b program in preclinical (pre-symptomatic) AD patients, initiated by collaboration partnerCash of CHF 103 million at year end, plus the CHF 15 million